Tags

Type your tag names separated by a space and hit enter

Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease.
Cartilage. 2020 Jun 09 [Online ahead of print]C

Abstract

OBJECTIVE

The objective of this study was to investigate the expression of enzymes involved in synthesis and modification of chondroitin sulfate (CS) in knee cartilage tissue of patients with osteoarthritis (OA) and Kashin-Beck disease (KBD).

METHODS

The knee articular cartilage samples were obtained from 18 age- and gender-matched donors with 6 each in KBD, OA, and control groups. Hematoxylin and eosin (HE) staining, toluidine blue (TB) staining, and immunohistochemical (IHC) staining were performed to estimate the expression level and localization of aggrecan, along with FAM20B, GalT-II, and EXTL2, which are associated with CS synthesis and modification. Rank-based analyses of variance test was used for the multiple comparisons of discrepancy in the positive staining rate among the 3 groups.

RESULTS

In HE and TB staining results, damaged morphology, decreased chondrocyte numbers and proteoglycans were observed in OA and KBD groups compared with the control group. In line with these trends, the positive staining rates of aggrecan were lower in KBD and OA groups than in the control group. Meanwhile, the positive staining rates of CS chain modifying enzymes FAM20B, GalT-II, and EXTL2 decreased in OA and KBD groups.

CONCLUSIONS

In conclusion, it was demonstrated that altered expression of CS chain modifying enzymes in OA and KBD groups influenced the synthesis procession of CS and could contribute to the damage of cartilage. Further investigation of these enzymes can provide new theoretical and experimental targets for OA and KBD pathogenesis studies.

Authors+Show Affiliations

School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China. Shenzhen Institute, Xi'an Jiaotong University, Shenzhen, Guangdong, People's Republic of China.School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.Department of Gastroenterology, the First Affiliated Hospital, Health Science Center of Xi'an Jiaotong University, Xi'an, People's Republic of China.School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China. Shenzhen Institute, Xi'an Jiaotong University, Shenzhen, Guangdong, People's Republic of China.School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China. Shenzhen Institute, Xi'an Jiaotong University, Shenzhen, Guangdong, People's Republic of China.School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China. Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32517548

Citation

Lei, Jian, et al. "Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients With Osteoarthritis and Kashin-Beck Disease." Cartilage, 2020, p. 1947603520932199.
Lei J, Deng H, Ran Y, et al. Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease. Cartilage. 2020.
Lei, J., Deng, H., Ran, Y., Lv, Y., Amhare, A. F., Wang, L., Guo, X., Han, J., & Lammi, M. J. (2020). Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease. Cartilage, 1947603520932199. https://doi.org/10.1177/1947603520932199
Lei J, et al. Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients With Osteoarthritis and Kashin-Beck Disease. Cartilage. 2020 Jun 9;1947603520932199. PubMed PMID: 32517548.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease. AU - Lei,Jian, AU - Deng,Huan, AU - Ran,Yan, AU - Lv,Yizhen, AU - Amhare,Abebe Feyissa, AU - Wang,Liyun, AU - Guo,Xiong, AU - Han,Jing, AU - Lammi,Mikko J, Y1 - 2020/06/09/ PY - 2020/6/11/entrez KW - Kashin-Beck disease KW - cartilage KW - chondroitin sulfate KW - immunohistochemistry KW - osteoarthritis SP - 1947603520932199 EP - 1947603520932199 JF - Cartilage JO - Cartilage N2 - OBJECTIVE: The objective of this study was to investigate the expression of enzymes involved in synthesis and modification of chondroitin sulfate (CS) in knee cartilage tissue of patients with osteoarthritis (OA) and Kashin-Beck disease (KBD). METHODS: The knee articular cartilage samples were obtained from 18 age- and gender-matched donors with 6 each in KBD, OA, and control groups. Hematoxylin and eosin (HE) staining, toluidine blue (TB) staining, and immunohistochemical (IHC) staining were performed to estimate the expression level and localization of aggrecan, along with FAM20B, GalT-II, and EXTL2, which are associated with CS synthesis and modification. Rank-based analyses of variance test was used for the multiple comparisons of discrepancy in the positive staining rate among the 3 groups. RESULTS: In HE and TB staining results, damaged morphology, decreased chondrocyte numbers and proteoglycans were observed in OA and KBD groups compared with the control group. In line with these trends, the positive staining rates of aggrecan were lower in KBD and OA groups than in the control group. Meanwhile, the positive staining rates of CS chain modifying enzymes FAM20B, GalT-II, and EXTL2 decreased in OA and KBD groups. CONCLUSIONS: In conclusion, it was demonstrated that altered expression of CS chain modifying enzymes in OA and KBD groups influenced the synthesis procession of CS and could contribute to the damage of cartilage. Further investigation of these enzymes can provide new theoretical and experimental targets for OA and KBD pathogenesis studies. SN - 1947-6043 UR - https://www.unboundmedicine.com/medline/citation/32517548/Altered_Expression_of_Aggrecan,_FAM20B,_B3GALT6,_and_EXTL2_in_Patients_with_Osteoarthritis_and_Kashin-Beck_Disease L2 - https://journals.sagepub.com/doi/10.1177/1947603520932199?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.